“Presentation of anxiety symptoms in patients with [major depressive disorder] is typically more complex to successfully treat with currently available medications,” Melissa Fickey, MD, founder of Embracing Life Wellness Center, said in a news release from Neuronetics.
The company tested its NeuroStar advanced therapy for mental health device on 664 patients diagnosed with major depressive disorder and found 65.5 percent of them showed a clinically meaningful response to the treatment.
In May, the FDA approved Neuronetics’ device for adjunct treatment of adults with obsessive compulsive disorder.
